1. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020) Authors: Wise-Draper, Trisha; Gulati, Shuchi; Takiar, Vinita; Palackdharry, Sarah; Worden, Francis; Old, Matthew; Kaczmar, John; Dunlap, Neal; Hinrichs, Benjamin; Bell, Diana; Patil, Yash; Riaz, Muhammad Kashif; Weatherford, Layne; Hamilton, Aubrey; Lanverman, Sheena; Mierzwa, Michelle; Casper, Keith; Mar... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival. (9th November 2020) Authors: Wise-Draper, Trisha; Gulati, Shuchi; Takiar, Vinita; Palackdharry, Sarah; Worden, Francis; Old, Matthew; Kaczmar, John; Dunlap, Neal; Hinrichs, Benjamin; Bell, Diana; Patil, Yash; Riaz, Muhammad Kashif; Weatherford, Layne; Hamilton, Aubrey; Lanverman, Sheena; Mierzwa, Michelle; Casper, Keith; Mar... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗